Company News

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") announces that the Company would like to highlight its COVID testing services in Ontario and British Columbia are available through clinic locations and concierge services seven (7) days a week.

Testing Reservation, Location Info and Price

  • Toronto: Please contact 416-901-8711 ext. 206, email travelon@screenprosecurity.com or visit at 6023 Yonge Street, main floor, Toronto, ON, M2M 3W2
  • Vancouver: Please contact 778-325-1418 or visit 1418 W Hastings, Vancouver, BC, V6G 3J6
TypeTorontoVancouver
Walk-InConciergeWalk-InConcierge
Rapid Antigen Test$49$69$49N/A
PCR - Regular (24-36hrs)$129$159$149$249
PCR - Rush (less than 12hrs)$159$199$189$289

 
* Note: 

  • Price may change without further notice
  • Travel certificate available upon request with no extra cost

Booking a COVID test is effortless and can be also done through the Company's website at ScreenPro Security Testing. ScreenPro offers both rapid antigen with results in fifteen (15) minutes, and the laboratory polymerase chain reaction ("PCR") testing in preparation for travel or prevention of spreading COVID.

Also, ScreenPro has an expanded medical team with doctors and nurses with its wholly owned subsidiary, Concierge Medical Consultants Inc. ("Concierge"), and can provide COVID testing for corporate and individuals in the comfort of your home or at a business or office location with preventative screening to determine the presence or absence of COVID.

ScreenPro provides travel documents for both PCR and antigen COVID test results upon request without an extra fee.

With over 314,000 confirmed active COVID-19 cases in Canada and with new highly contagious Omicron (B.1.1.529) variant, testing will remain a front-line tool to reduce cases in Canada as people can be asymptomatic and spread the new variant and those who are exposed appear to get sick faster and may have symptoms that are different than those of other variants.

"With the Omicron variant rolling through communities and case counts hitting an all-time-high, it is important to get tested and stop the spread of Omicron and keeping the countries hospital ICU's from hitting capacity. We have the medical staff and lab capacity to deliver COVID testing in Toronto and Vancouver area," stated Lena Kozovski, CEO of the Company.

About Concierge

Concierge Medical Consultants is a small group of board-certified practicing emergency physicians who think that urgent care does not just happen in an ER or your doctor's office, it can happen anywhere at any time. Dr Jibran Sharif, MD, CCFP EM, RDMS, is the founder and CEO of Concierge Medical Consultants and grew up in Vancouver. He earned a degree in Economics at the University of British Columbia before graduating with a medical degree and residencies in Emergency Medicine and Ultrasound at the University of Sydney, University of Saskatchewan, and the University of Calgary, respectively. He is a full time Emergency physician in the GVRD and a Clinical lecturer with the faculty of Emergency Medicine at the University of British Columbia.

For additional information, please visit Concierge's website at www.conciergemedical.ca

About ScreenPro

ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allowing ScreenPro to be a full-service nationwide provider of COVID testing solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals along with on the ground support staff and transportation, as access to high quality PPEs to ensure that its clients are protected in all aspects of their testing needs. ScreenPro provides alerting software through its secure GoStop application that enables individuals to use the app for test screening results as well as provides automated identification codes for our laboratories and analytics to our clients on their testing cadence. For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com

For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.

Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information please contact:
Jamie Hyland, Director
Email: info@screenprosecurity.com
P. (604) 442-2425

Forward-Looking Statements:

Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding the business of Concierge Medical Consultants Inc. and the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.

###

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/109226

News Provided by Newsfile via QuoteMedia

SCRN:CC
ScreenPro Provides Update on Concierge Medical Business Operations

ScreenPro Provides Update on Concierge Medical Business Operations

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that Concierge Medical Consultants Inc. ("Concierge") has been capitalizing on the lucrative custom care market and has been extensively growing its client base to help provide personalized healthcare to Canadians. The Company continues to grow its revenue in this vertical and looks forward to sharing Q1 revenue results from Concierge at the end of this month.

The public health care system is facing unprecedented demand with patients routinely waiting over 10 hours in an emergency department for care. In the covid era, primary care is becoming increasingly difficult to access with many doctors seeing patients virtually. Patients are turning to a more personalized formula of concierge care with no time limits, no more hurried appointments or long wait times. (Source: Dr. Jibran Sharif, MD.)

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
The Power Play by The Market Herald Releases New Interview with ScreenPro Security

The Power Play by The Market Herald Releases New Interview with ScreenPro Security

The Power Play by The Market Herald has announced the release of a new interview with ScreenPro Security on their latest news

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
ScreenPro Announces Acquisition of Naturevan Nutrition Ltd.

ScreenPro Announces Acquisition of Naturevan Nutrition Ltd.

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that it has completed the acquisition of Naturevan Nutrition Ltd. ("Naturevan"), a privately-held British Columbia corporation, focused on the health and wellness industry. Naturevan has 22 natural health supplement products that are sold online and through distribution agents.

The acquisition of Naturevan provides ScreenPro an entry into the health and wellness space with immediate sales, an e-commerce team, and established sales distribution channel. Naturevan is strategic to ScreenPro as it provides immediate diversification, growth opportunities through its sales channels and online platform, and synergies with Concierge Medical as it provides product offerings to clients and future expandability of business lines.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ScreenPro Provides Update on Business Operations

ScreenPro Provides Update on Business Operations

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that the Company has administered 29,519 Covid-19 tests in April, an increase of 15% compared to March's Covid testing numbers of 25,517.

With the recent news of Toronto's mayor terminating the Covid-19 emergency declaration that was put in place at the beginning of the pandemic in March 2020 and the surge of cases with the new omicron subvariants world-wide, the Company is confident that Covid testing numbers and market share will continue to increase significantly as testing demand is growing each month within the community.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
American Manganese Delivers NMC-811 Cathode Precursor from Recycled Lithium-ion Battery Material

American Manganese Delivers NMC-811 Cathode Precursor from Recycled Lithium-ion Battery Material

Highlights:

  • NMC-811 cathode precursor delivered to active collaborators in North America, Europe, and Asia
  • Recycled material to be third-party analyzed and battery performance tested
  • Internal analysis indicates product specifications are within desired industry ranges
  • NMC-811 cathode precursor recycled and upcycled from electric vehicle black mass

American Manganese Inc. (TSXV:AMY)(OTCQB:AMYZF)(FSE:2AM) ("AMY" or the "Company"), a pioneer in advanced and environmentally friendly lithium-ion battery cathode recycling-upcycling, is pleased to provide an update on its technology and partnership development strategy

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
ScreenPro Reports Annual Financial Results with Record Revenues of over $21 Million

ScreenPro Reports Annual Financial Results with Record Revenues of over $21 Million

  • Record Revenues of over $21 Million
  • Momentum of core Covid business continues into 2022

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that the Company has reported over $21 million of revenue. The Company filed on SEDAR its financial statements ("FS") and related management discussion and analysis ("MD&A") for the year end results ending December 31, 2021 ("Q4 2021").

2021 Financial Summary

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ScreenPro Building Cash Position With Continued Growth In Covid Testing Numbers

ScreenPro Building Cash Position With Continued Growth In Covid Testing Numbers

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report a significant increase in the Covid-19 testing numbers this year, which attributes to the Company's stronger cash position. Covid testing remains in high demand for the film and production industry. Due to the nature of the work environment, staff members are often operating in contained areas and in close proximity. With various highly contagious variants, such as Omicron and the numbers of infections increasing, we foresee more contracts throughout 2022.

The Company also faces a rise in demand for testing in the travel and tourism industry along with its concierge (home/office visit) services. In addition to the news release on March 24th, 2022, the Company has received three additional testing contracts in television and production dated as of April 8, 2022, resulting in a total of 21 new productions to date for Q1 of FY22.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ScreenPro Insiders Acquire Additional Shares

ScreenPro Insiders Acquire Additional Shares

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that further to the press release on April 4, 2022, certain members of the Board of Directors and Senior Management have further increased their positions in the Company by purchasing additional shares in open-market transactions between April 5, 2022, and April 6, 2022, for an additional 1,680,000. Details of the purchase is as follows:

  • Michael Yeung, Chairman, purchased 435,000 shares at an average price of $0.068
  • Lena Kozovski, CEO, purchased 395,000 shares at an average price of $0.07
  • Paul Haber, CFO, purchased 400,000 shares at an average price of $0.07
  • Youngcho Lee, Director, purchased 450,000 shares at an average price of $0.067

Over the past two weeks, certain members of the Board of Directors and Senior Management accumulated a total of 4,521,000, representing 6.1% of the total outstanding shares of 74,638,916.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ScreenPro Announces Insider Purchases of Shares

ScreenPro Announces Insider Purchases of Shares

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that certain members of the Board of Directors and Senior Management have purchased 2,841,600 shares of the Company between March 29, 2022, to March 31, 2022, in open-market transactions. Details of the purchase is as follows:

Michael Yeung, Chairman, purchased 660,000 shares at an average price of $0.075

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Add Biomedical Submits Application to USPTO for Rapid Breast Cancer Screening

Add Biomedical Submits Application to USPTO for Rapid Breast Cancer Screening

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that the Company's wholly owned subsidiary, Add Biomedical Inc. (Add Bio), is strengthening its library of intellectual property (IP). The Company has applied for the Cancer Antigen (CA) 15-3 rapid testing kit for breast cancer screening to the United States Patent and Trademark Office (USPTO).

Breast cancer is the world's most commonly occurring cancer. According to Cancer.ca, breast cancer is the second leading cause of cancer deaths in Canadian women. Recent reports show that 76 Canadian women are diagnosed with breast cancer everyday and on average, 15 of those women die from the disease everyday. (Source: Canadian Cancer Society)

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×